FDA Inspection
Armstrong Pharmaceuticals, Inc.Armstrong Pharmaceuticals, Inc. – FDA Inspection, Jun 14, 2012
Record Details
This FDA Inspection record concerns Armstrong Pharmaceuticals, Inc., with an inspection on June 14, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 14, 2012
- Product Type
- Drugs
View Company Profile
ID · fb0392ac-db34-4203-9057-722ff702bcd5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 785248
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Armstrong Pharmaceuticals, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | VAI | New England District Office | Drug Quality Assurance |
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 14, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 5, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Armstrong Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.